“If data were the new oil, China would be Saudi Arabia.” But can artificial intelligence someday transform these data fields into pharmaceutical R&D nirvana?
Want to dig deeper into healthcare innovation in China?
-
Article
Use of Microblog "Weibo" by Chinese Patent Medicine Companies in China
Read Now
Qirui Song, Carolina Oi Lam Ung, Daisheng Tang, Hao Hu
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
DIA China 2019: Aspiration to Drive Healthcare Innovation
Read Now
Ling Su, Lilly Asia Ventures; Shenyang Pharmaceutical University, Institute of Drug Regulatory Science
Global Forum -
Podcast
Has Joining ICH Accelerated Innovation in China?
Listen Now
Jingsong Wang, Harbour Biomed, DIA 2019 Excellence in Service Award Winner -
Article
Improving Clinical Data Quality and Trial Efficiency in China
Read Now
Charles Yan, Clinical Data Science Center, Hengrui Medicine
Global Forum -
Podcast
AI Research Can Optimize Clinical/Operational Effectiveness
Listen Now
John Lim, Duke-National University of Singapore Centre of Regulatory Excellence -
Article
Opportunities & Challenges of Multinational Pharmaceutical Enterprises in Transforming Pharmaceutical Market in China
Read Now
Linfeng Hu, Zhong Yu, Qingwen Yuan, Yuanjia Hu, Carolina Oi Lam Ung
Therapeutic Innovation & Regulatory Science
Member-only content
Want to learn more?
Plan to attend upcoming DIA events in China, including our 2019 Quantitative Science Forum in August and 5th DIA China Drug Discovery Innovation Conference in October.